105 related articles for article (PubMed ID: 30237305)
1. Safety of biweekly α
Greulich T; Chlumsky J; Wencker M; Vit O; Fries M; Chung T; Shebl A; Vogelmeier C; Chapman KR; McElvaney NG;
Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30237305
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary Emphysema in a Child With Alpha-1 Antitrypsin Deficiency: Evaluation of 2 Years of Intravenous Augmentation Therapy.
Esteves Brandão M; Conde B; Seixas S; Clotilde Silva J; Fernandes A
Arch Bronconeumol (Engl Ed); 2019 Sep; 55(9):502-504. PubMed ID: 30871819
[No Abstract] [Full Text] [Related]
3. Efficacy and safety of inhaled α1-antitrypsin in patients with severe α1-antitrypsin deficiency and frequent exacerbations of COPD.
Stolk J; Tov N; Chapman KR; Fernandez P; MacNee W; Hopkinson NS; Piitulainen E; Seersholm N; Vogelmeier CF; Bals R; McElvaney G; Stockley RA
Eur Respir J; 2019 Nov; 54(5):. PubMed ID: 31467115
[TBL] [Abstract][Full Text] [Related]
4. Are There Differences Between the Available Treatments for Emphysema Associated with Alpha-1 Antitrypsin Deficiency?
Esquinas C; Miravitlles M
Arch Bronconeumol (Engl Ed); 2018 Sep; 54(9):451-452. PubMed ID: 29625713
[No Abstract] [Full Text] [Related]
5. Alpha
Strnad P; McElvaney NG; Lomas DA
N Engl J Med; 2020 Apr; 382(15):1443-1455. PubMed ID: 32268028
[No Abstract] [Full Text] [Related]
6. Alpha-1 Antitrypsin Deficiency and Pregnancy.
Gaeckle NT; Stephenson L; Reilkoff RA
COPD; 2020 Jun; 17(3):326-332. PubMed ID: 32308050
[TBL] [Abstract][Full Text] [Related]
7. [Longterm Homecare Augmentation Program in Alpha-1-Antitrypsin Deficient Patients].
Wilke A; Semper H; Gross C; Grohé C
Pneumologie; 2018 Aug; 72(8):590-597. PubMed ID: 30089330
[TBL] [Abstract][Full Text] [Related]
8. Blockade of Dopamine D2 Receptors as a Novel Approach to Stimulation of Notch1
Skurikhin EG; Krupin VA; Pershina OV; Pan ES; Pakhomova AV; Sandrikina LA; Ermakova NN; Vaizova OE; Zhukova MA; Dygai AM
Bull Exp Biol Med; 2020 Apr; 168(6):718-723. PubMed ID: 32328949
[TBL] [Abstract][Full Text] [Related]
9. Safety and pharmacokinetics of Alpha-1 MP (Prolastin
Seyama K; Nukiwa T; Sato T; Suzuki M; Konno S; Takahashi K; Nishimura M; Steinmann K; Sorrells S; Chen J; Hayashi KI
Respir Investig; 2019 Jan; 57(1):89-96. PubMed ID: 30416054
[TBL] [Abstract][Full Text] [Related]
10. [Alpha-1 Antitrypsin Deficiency (AATD) - D-A-CH-Expert Statement].
Greulich T; Fähndrich S; Clarenbach C; Gleiber W; Hautmann H; Heine R; Idzko M; Schmidt-Scherzer K; Skowasch D; Wiewrodt R; Bals R; Koczulla AR
Pneumologie; 2020 Jul; 74(7):436-442. PubMed ID: 32492720
[No Abstract] [Full Text] [Related]
11. Diagnosis and management of patients with α1-antitrypsin (A1AT) deficiency.
Nelson DR; Teckman J; Di Bisceglie AM; Brenner DA
Clin Gastroenterol Hepatol; 2012 Jun; 10(6):575-80. PubMed ID: 22200689
[TBL] [Abstract][Full Text] [Related]
12. Consequences of Abrupt Cessation of Alpha
McElvaney OJ; Carroll TP; Franciosi AN; Sweeney J; Hobbs BD; Kowlessar V; Gunaratnam C; Reeves EP; McElvaney NG
N Engl J Med; 2020 Apr; 382(15):1478-1480. PubMed ID: 32268034
[No Abstract] [Full Text] [Related]
13. Unravelling the risk of (intermediate) antitrypsin deficiency.
Quinn M; Turner AM; Mahadeva R
Thorax; 2021 Mar; 76(3):214-215. PubMed ID: 33268455
[No Abstract] [Full Text] [Related]
14. Alpha-1 Antitrypsin Deficiency: Does Increased Neutrophil Adhesion Contribute to Lung Damage?
Prendecki M; Lodge KM
Am J Respir Cell Mol Biol; 2022 Jul; 67(1):6-7. PubMed ID: 35522757
[No Abstract] [Full Text] [Related]
15. Comparison of the liquid and lyophilized formulations of Prolastin®-C for Alpha
Arora V; Cruz M; Lang J; Klos AM; Merritt WK; Price J; Taylor G; Vandeberg P; Wee K; Willis T
Biologicals; 2019 Nov; 62():77-84. PubMed ID: 31522909
[TBL] [Abstract][Full Text] [Related]
16. Ataluren, a New Therapeutic for Alpha-1 Antitrypsin-Deficient Individuals with Nonsense Mutations.
Reeves EP; O'Dwyer CA; Dunlea DM; Wormald MR; Hawkins P; Alfares M; Kotton DN; Rowe SM; Wilson AA; McElvaney NG
Am J Respir Crit Care Med; 2018 Oct; 198(8):1099-1102. PubMed ID: 30011228
[No Abstract] [Full Text] [Related]
17. A Role for Hepatic Insulin Signaling in α1-Antitrypsin Deficiency.
Copps KD; Tao R
Gastroenterology; 2022 Jul; 163(1):49-51. PubMed ID: 35500618
[No Abstract] [Full Text] [Related]
18. Intravenous Alpha-1 Antitrypsin Therapy for Critically Ill COVID-19 Patients.
Wand O; Dahan D; Tov N; Epstein Shochet G; King DA; Shitrit D
Isr Med Assoc J; 2022 Jul; 24(7):441-443. PubMed ID: 35819210
[No Abstract] [Full Text] [Related]
19. A therapeutic challenge: managing severe atopic dermatitis with concurrent alpha-1-antitrypsin deficiency.
Cebolla-Verdugo M; Llamas-Segura C; Linares-González L; Ruiz-Villaverde R; Navarro-Triviño FJ
J Dermatolog Treat; 2024 Dec; 35(1):2307495. PubMed ID: 38258513
[No Abstract] [Full Text] [Related]
20. Effect of α
Vianello A; Caminati M; Senna G; Arcolaci A; Chieco-Bianchi F; Ferrarotti I; Guarnieri G; Molena B; Crisafulli E
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1414-1416. PubMed ID: 33440256
[No Abstract] [Full Text] [Related]
[Next] [New Search]
